By Jaime Llinares Taboada

 

Koninklijke Philips N.V. said Friday that it is resuming the manufacturing and distribution of defibrillators in the U.S. after the Food and Drug Administration lifted its prohibition on those activities.

The health-technology group said it had been required to suspend those activities pending FDA certification of Philips' compliance with U.S. regulations.

 

Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT

 

(END) Dow Jones Newswires

April 24, 2020 03:38 ET (07:38 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Koninklijke Philips NV Charts.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Koninklijke Philips NV Charts.